Clinical Trial Update: Safety, Tolerability, PK, and Efficacy of CD-001 in Advanced Head & Neck Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CD-001 in advanced head and neck cancer. The study assesses safety, tolerability, pharmacokinetics, and preliminary efficacy s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CD-001 (CD-001)

Snippet

Sponsor: West China Hospital | Conditions: Malignant Neoplasm, Head &Amp; Neck Cancer | Phase 1 | Status: NOT_YET_RECRUITING